Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Apr;55(4):681–690. doi: 10.1172/JCI107977

Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.

G Schneider, M Genel, A M Bongiovanni, A S Goldman, R L Rosenfield
PMCID: PMC301803  PMID: 164481

Abstract

A partial testicular defect in testosterone secretion has been documented in a pubertal male with a congenital adrenal hyperplasia due to hereditary deficiency of the delta5-isomerase-3beta-hydroxysteroid dehydrogenase enzyme complex (delta5-3beta-HSD). Diagnosis of the enzymatic defect is based on the clinical picture of ambiguous genitalia and salt-losing crisis in infancy, together with high urinary delta5-pregnenetriol and plasma dehydroepiandrosterone when the patient was taken off replacement corticoid treatment. No hormonal response to ACTH or salt deprivation was demonstrable. In addition, in vivo studies revealed a partial enzymatic defect in the testis. Although plasma testosterone was low-normal (250 ng/100 ml), plasma delta5-androstenediol was markedly elevated and rose to a greater extent than testosterone after human chorionic gonadotropin administration. In vitro testicular incubation studies suggested a testicular delta5-3beta-HSD enzyme defect with less delta4 products formed from delta5 precursors than in a control testis. Histochemical studies of the testis were also consistent with this defect. Testicular biopsy revealed spermatogenic arrest, generally diminished Leydig cells, but with focal areas of Leydig cell hyperplasia as well as benign Leydig cell hyperplasia as well as benign Leudig cell nodules within the spermatic cord. In vivo studies of steroid metabolism suggested intact peripheral or hepatic delta5-3beta-HSD activity. These studies imply that delta5-3beta-HSD activity differs in the gonad, adrenal, and peripheral organs. These findings are compatible with the concept that the enzyme complex consists of subunits and/or that enzymes in these organs are under different genetic control.

Full text

PDF
681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BONGIOVANNI A. M., ROOT A. W. The adrenogenital syndrome. N Engl J Med. 1963 Jun 6;268:1283–contd. doi: 10.1056/NEJM196306062682308. [DOI] [PubMed] [Google Scholar]
  2. BONGIOVANNI A. M. The adrenogenital syndrome with deficiency of 3 beta-hydroxysteroid dehydrogenase. J Clin Invest. 1962 Nov;41:2086–2092. doi: 10.1172/JCI104666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Björkhem I., Gustafsson J. A., Gustafsson S. A. Metabolism of steroids in germfree and conventional rats treated with a 3-beta-Hydroxy-delta-5-steroid oxidoreductase inhibitor. Eur J Biochem. 1970 Nov;16(3):557–566. doi: 10.1111/j.1432-1033.1970.tb01117.x. [DOI] [PubMed] [Google Scholar]
  4. Bloch E., Lew M., Klein M. Studies on the inhibition of fetal androgen formation. Inhibition of testosterone synthesis in rat and rabbit fetal testes with observations on reproductive tract development. Endocrinology. 1971 Jul;89(1):16–31. doi: 10.1210/endo-89-1-16. [DOI] [PubMed] [Google Scholar]
  5. Bongiovanni A. M., Eberlein W. R., Goldman A. S., New M. Disorders of adrenal steroid biogenesis. Recent Prog Horm Res. 1967;23:375–449. doi: 10.1016/b978-1-4831-9826-2.50012-x. [DOI] [PubMed] [Google Scholar]
  6. Bongiovanni A. M., Eberlein W. R., Moshang T., Jr Urinary excretion of pregnanetriol and 5 -pregnenetriol in two forms of congenital adrenal hyperplasia. J Clin Invest. 1971 Dec;50(12):2751–2754. doi: 10.1172/JCI106777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cargille C. M., Ross G. T., Yoshimi T. Daily variations in plasma follicle stimulating hormone, luteinizing hormone and progesterone in the normal menstrual cycle. J Clin Endocrinol Metab. 1969 Jan;29(1):12–19. doi: 10.1210/jcem-29-1-12. [DOI] [PubMed] [Google Scholar]
  8. DAHL E. V., BAHN R. C. Aberrant adrenal contical tissue near the testis in human infants. Am J Pathol. 1962 May;40:587–598. [PMC free article] [PubMed] [Google Scholar]
  9. Demisch K., Magnet W., Neubauer M., Schöffling K. Studies about unconjugated androstenediol in human peripheral plasma. J Clin Endocrinol Metab. 1973 Jul;37(1):129–134. doi: 10.1210/jcem-37-1-129. [DOI] [PubMed] [Google Scholar]
  10. Fore W. W., Bledsoe T., Weber D. M., Akers R., Brooks R. T., Jr Cortisol production by testicular tumors in adrenogenital syndrome. Arch Intern Med. 1972 Jul;130(1):59–63. [PubMed] [Google Scholar]
  11. GOLDMAN A. S., BONGIOVANNI A. M., YAKOVAC W. C., PRADER A. STUDY OF DELTA-5, 3-BETA-HYDROXYSTEROID DEHYDROGENASE IN NORMAL, HYPERPLASTIC AND NEOPLASTIC ADRENAL CORTICAL TISSUE. J Clin Endocrinol Metab. 1964 Sep;24:894–909. doi: 10.1210/jcem-24-9-894. [DOI] [PubMed] [Google Scholar]
  12. Goldman A. S., Baker M. K., Stanek A. E. Development of delta 5,3 beta-hydroxxysteroid and glucose-6-phosphate dehydrogenase in the testes, adrenals and ovaries of the rabbit fetus. Proc Soc Exp Biol Med. 1972 Sep;140(4):1486–1492. doi: 10.3181/00379727-140-36701. [DOI] [PubMed] [Google Scholar]
  13. Goldman A. S., Bongiovanni A. M., Yakovac W. C. Production of congenital adrenal cortical hyperplasia, hypospadias, and clitoral hypertrophy (adrenogenital syndrome) in rats by inactivation of 3-beta-hydroxysteroid dehydrogenase. Proc Soc Exp Biol Med. 1966 Mar;121(3):757–766. doi: 10.3181/00379727-121-30879. [DOI] [PubMed] [Google Scholar]
  14. Goldman A. S. Experimental congenital adrenocortical hyperplasia: persistent postnatal deficiency in activity of 3-beta-hydroxysteroid dehydrogenase produced in utero. J Clin Endocrinol Metab. 1967 Jul;27(7):1041–1049. doi: 10.1210/jcem-27-7-1041. [DOI] [PubMed] [Google Scholar]
  15. Goldman A. S. Inhibition of 3 -hydroxy- 5 -steroid dehydrogenase. Gynecol Invest. 1971;2(1):213–238. doi: 10.1159/000301863. [DOI] [PubMed] [Google Scholar]
  16. Goldman A. S. Rat fetal target organ delta-5, 3 beta-hydroxysteroid dehydrogenase: effect of cyanoketone and cyproterone acetate. Endocrinology. 1973 Apr;92(4):1043–1050. doi: 10.1210/endo-92-4-1043. [DOI] [PubMed] [Google Scholar]
  17. Greenwood S. M., Forman B. H., Goodman J. R., Kress S. C., Schneider G., Gelb A. F. Choriocarcinoma in a man. The relationship of gynecomastia to chorionic somatomammotropin and estrogens. Am J Med. 1971 Sep;51(3):416–422. doi: 10.1016/0002-9343(71)90278-6. [DOI] [PubMed] [Google Scholar]
  18. HAMILTON W., BRUSH M. G. FOUR CLINICAL VARIANTS OF CONGENITAL ADRENAL HYPERPLASIA. Arch Dis Child. 1964 Feb;39:66–72. doi: 10.1136/adc.39.203.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jänne O., Perheentupa J., Vihko R. Plasma and urinary steroids in an eight-year-old boy with 3-beta-hydxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1970 Aug;31(2):162–165. doi: 10.1210/jcem-31-2-162. [DOI] [PubMed] [Google Scholar]
  20. Jänne O., Perheentupa J., Viinikka L., Vihko R. Testicular endocrine function in a pubertal boy with 3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1974 Jul;39(1):206–209. doi: 10.1210/jcem-39-1-206. [DOI] [PubMed] [Google Scholar]
  21. KLIMAN B., PETERSON R. E. Double isotope derivative assay of aldosterone in biological extracts. J Biol Chem. 1960 Jun;235:1639–1648. [PubMed] [Google Scholar]
  22. Kenny F. M., Reynolds J. W., Green O. C. Partial 3 -hydroxysteroid dehydrogenase (3 -HSD) deficiency in a family with congenital adrenal hyperplasia: evidence for increasing 3 -HSD activity with age. Pediatrics. 1971 Nov;48(5):756–765. [PubMed] [Google Scholar]
  23. Kirschner M. A., Sinhamahapatra S., Zucker I. R., Loriaux L., Nieschiag E. The production, origin and role of dehydroepiandrosterone and delta 5-androstenediol as androgen prehormones in hirsute women. J Clin Endocrinol Metab. 1973 Aug;37(2):183–189. doi: 10.1210/jcem-37-2-183. [DOI] [PubMed] [Google Scholar]
  24. Laatikainen T., Laitinen E. A., Vihko R. Secretion of free and sulfate-conjugated neutral steroids by the human testis. Effect of administration of human chorionic gonadotropin. J Clin Endocrinol Metab. 1971 Jan;32(1):59–64. doi: 10.1210/jcem-32-1-59. [DOI] [PubMed] [Google Scholar]
  25. Laatikainen T., Perheentupa J., Vihko R., Makino I., Sjövall J. Bile acids and hormonal steroids in bile of a boy with 3 -hyseoxysteroid dehydrogenase deficiency. J Steroid Biochem. 1972 Jun;3(4):715–719. doi: 10.1016/0022-4731(72)90062-3. [DOI] [PubMed] [Google Scholar]
  26. Murphy B. E. Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay. J Clin Endocrinol Metab. 1967 Jul;27(7):973–990. doi: 10.1210/jcem-27-7-973. [DOI] [PubMed] [Google Scholar]
  27. Neumann F., Elger W. [The effect of the anti-androgen 1,2-alpha-methylene-6-chloro-delta-4,6-pregnadiene-17-alpha-ol-3,20-dione-17-alpha-acetate (cyproterone acetate) on the development of the mammary glands of male foetal rats]. J Endocrinol. 1966 Dec;36(4):347–352. doi: 10.1677/joe.0.0360347. [DOI] [PubMed] [Google Scholar]
  28. Neumann F., Goldman A. S. Prevention of Mammary gland defects in experimental congenital adrenal hyperplasia due to inhibition to 3 beta-hydroxysteroid dehydrogenase in rats. Endocrinology. 1970 May;86(5):1169–1171. doi: 10.1210/endo-86-5-1169. [DOI] [PubMed] [Google Scholar]
  29. Odell W. D., Ross G. T., Rayford P. L. Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest. 1967 Feb;46(2):248–255. doi: 10.1172/JCI105527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Rosenfield R. L. A competitive protein binding method for the measurement of plasma androstenedione. Steroids. 1969 Sep;14(3):251–261. doi: 10.1016/0039-128x(69)90013-0. [DOI] [PubMed] [Google Scholar]
  31. Rosenfield R. L. A competitive protein binding method for the measurement of unconjugated and sulfate-conjugated dehydroepiandrosterone in peripheral plasma. Steroids. 1971 Jun;17(6):689–696. doi: 10.1016/0039-128x(71)90084-5. [DOI] [PubMed] [Google Scholar]
  32. Rosenfield R. L., Barmach de Niepomniszsze A., Kenny F. M., Genel M. The response to human chorionic gonadotropin (HCG) administration in boys with and without delta5-3beta-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab. 1974 Aug;39(2):370–374. doi: 10.1210/jcem-39-2-370. [DOI] [PubMed] [Google Scholar]
  33. Rosenfield R. L., Eberlein W. R., Bongiovanni A. M. Measurement of plasma testosterone by means of competitive protein binding analysis. J Clin Endocrinol Metab. 1969 Jun;29(6):854–859. doi: 10.1210/jcem-29-6-854. [DOI] [PubMed] [Google Scholar]
  34. Rosenfield R. L., Grossman B. J., Ozoa N. Plasma 17-ketosteroids and testosterone in prepubertal children before and after ACTH administration. J Clin Endocrinol Metab. 1971 Aug;33(2):249–253. doi: 10.1210/jcem-33-2-249. [DOI] [PubMed] [Google Scholar]
  35. Rosenfield R. L., Otto P. Androstenediol levels in human peripheral plasma. J Clin Endocrinol Metab. 1972 Dec;35(6):818–822. doi: 10.1210/jcem-35-6-818. [DOI] [PubMed] [Google Scholar]
  36. Ruder H. J., Loriaux D. L., Sherins R. J., Lipsett M. B. Leydig cell function in men with disorders of spermatogenesis. J Clin Endocrinol Metab. 1974 Feb;38(2):244–247. doi: 10.1210/jcem-38-2-244. [DOI] [PubMed] [Google Scholar]
  37. SAVARD K., DORFMAN R. I., BAGGETT B., FIELDING L. L., ENGEL L. L., McPHERSON H. T., LISTER L. M., JOHNSON D. S., HAMBLEN E. C., ENGEL F. L. Clinical, morphological and biochemical studies of a virilizing tumor in the testis. J Clin Invest. 1960 Mar;39:534–553. doi: 10.1172/JCI104067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. SHANKLIN D. R., RICHARDSON A. P., Jr, ROTHSTEIN G. TESTICULAR HILAR NODULES IN ADRENOGENITAL SYNDROME. THE NATURE OF THE NODULES. Am J Dis Child. 1963 Sep;106:243–250. doi: 10.1001/archpedi.1963.02080050245001. [DOI] [PubMed] [Google Scholar]
  39. Schneider G., Bardin C. W. Defective testicular testosterone synthesis by the pseudohermaphrodite rat: an abnormality of 17 beta-hydroxysteroid dehydrogenase. Endocrinology. 1970 Nov;87(5):864–873. doi: 10.1210/endo-87-5-864. [DOI] [PubMed] [Google Scholar]
  40. Skinner S. L. Improved assay methods for renin "concentration" and "activity" in human plasma. Methods using selective denaturation of renin substrate. Circ Res. 1967 Apr;20(4):391–402. doi: 10.1161/01.res.20.4.391. [DOI] [PubMed] [Google Scholar]
  41. Sobrinho L. G., Kase N. G., Grunt J. A. Changes in adrenocortisol function of patients with gonadal dysgenesis after treatment with estrogen. J Clin Endocrinol Metab. 1971 Jul;33(1):110–114. doi: 10.1210/jcem-33-1-110. [DOI] [PubMed] [Google Scholar]
  42. Speroff L., Caldwell B. V., Brock W. A., Anderson G. G., Hobbins J. C. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion. J Clin Endocrinol Metab. 1972 Mar;34(3):531–536. doi: 10.1210/jcem-34-3-531. [DOI] [PubMed] [Google Scholar]
  43. Strott C. A., Bermudez J. A., Lipsett M. B. Blood levels and production rate of 17-hydroxypregnenolone in man. J Clin Invest. 1970 Nov;49(11):1999–2007. doi: 10.1172/JCI106420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yanaihara T., Troen P. Studies of the human testis. II. A study of androstenediol and its monosulfate in human testes in vitro. J Clin Endocrinol Metab. 1972 May;34(5):793–800. doi: 10.1210/jcem-34-5-793. [DOI] [PubMed] [Google Scholar]
  45. Yanaihara T., Troen P., Troen B. R., Troen M. L. Studies of the human testis. 3. Effect of estrogen on testosterone formation in human testis in vitro. J Clin Endocrinol Metab. 1972 Jun;34(6):968–973. doi: 10.1210/jcem-34-6-968. [DOI] [PubMed] [Google Scholar]
  46. Zachmann M., Vollmin J. A., Murset G., Curtius H. C., Prader A. Unusual type of congenital adrenal hyperplasia probably due to deficiency of 3-beta-hydroxysteroid dehydrogenase. Case report of a surviving girl and steroid studies. J Clin Endocrinol Metab. 1970 Jun;30(6):719–726. doi: 10.1210/jcem-30-6-719. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES